Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases

Anirudh P Shanbhag1,2, Purnendu Bhowmik1,3

  • 1Bugworks Research India Pvt. Ltd., Bengaluru, Karnataka, India.

Insights

Aldo-keto reductases (AKRs) are versatile enzymes involved in human metabolic pathways. Their promiscuity, while beneficial for microbial resistance, can lead to chronic diseases when exposed to synthetic compounds.

Area of Science:

  • Biochemistry
  • Enzymology
  • Human Physiology

Background:

  • Aldo-keto reductases (AKRs) are a superfamily of enzymes crucial for numerous human regulatory pathways.
  • AKRs exhibit significant promiscuity, acting as a double-edged sword in biological systems.
  • This enzyme superfamily is implicated in various metabolic processes and linked to chronic conditions like diabetes and cancer.

Purpose of the Study:

  • To explore the dual role of aldo-keto reductases (AKRs) in human health and disease.
  • To understand the implications of AKR promiscuity in the context of modern environmental exposures.

Main Methods:

  • Comparative analysis of AKR functions across species.
  • Review of literature on AKR involvement in metabolic pathways and disease.
  • Examination of the impact of synthetic substrates on AKR activity.

Main Results:

  • AKRs are widely distributed with interchangeable functions, unlike other detoxifying enzymes.
  • AKR promiscuity aids in resisting pathogenic microbes.
  • Exposure to synthetic molecules and processed foods can lead to "toxification" via AKRs, contributing to chronic diseases.

Conclusions:

  • The inherent promiscuity of aldo-keto reductases presents both protective and detrimental effects.
  • Understanding AKR activity is critical for addressing chronic diseases linked to environmental and dietary factors.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.8K
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
197
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Overview of Metabolism01:40

Overview of Metabolism

Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
29.8K
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
264
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation02:17

Reduction of Alkenes: Asymmetric Catalytic Hydrogenation

Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.3K